199 related articles for article (PubMed ID: 12241118)
1. Olfactory neuroblastomas: survival rate and prognostic factor.
Hwang SK; Paek SH; Kim DG; Jeon YK; Chi JG; Jung HW
J Neurooncol; 2002 Sep; 59(3):217-26. PubMed ID: 12241118
[TBL] [Abstract][Full Text] [Related]
2. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
3. Optimization of long-term outcomes for patients with esthesioneuroblastoma.
Ow TJ; Hanna EY; Roberts DB; Levine NB; El-Naggar AK; Rosenthal DI; DeMonte F; Kupferman ME
Head Neck; 2014 Apr; 36(4):524-30. PubMed ID: 23780581
[TBL] [Abstract][Full Text] [Related]
4. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
5. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.
Yu Y; El-Sayed IH; McDermott MW; Theodosopoulos PV; van Zante A; Kased N; Glastonbury CM; Garsa AA; Yom SS
Laryngoscope; 2018 Oct; 128(10):2226-2233. PubMed ID: 29427378
[TBL] [Abstract][Full Text] [Related]
6. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
[TBL] [Abstract][Full Text] [Related]
7. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
8. Esthesioneuroblastoma in children and adolescent: experience on 11 cases with literature review.
El Kababri M; Habrand JL; Valteau-Couanet D; Gaspar N; Dufour C; Oberlin O
J Pediatr Hematol Oncol; 2014 Mar; 36(2):91-5. PubMed ID: 24390450
[TBL] [Abstract][Full Text] [Related]
9. Advantage of Extended Craniofacial Resection for Advanced Malignant Tumors of the Nasal Cavity and Paranasal Sinuses: Long-Term Outcome and Surgical Management.
Sakata K; Maeda A; Rikimaru H; Ono T; Koga N; Takeshige N; Tokutomi T; Umeno H; Kiyokawa K; Morioka M
World Neurosurg; 2016 May; 89():240-54. PubMed ID: 26875653
[TBL] [Abstract][Full Text] [Related]
10. [Olfactory neuroblastoma: the Hokkaido University experience].
Kano S; Furuta Y; Homma A; Oridate N; Higuchi E; Suzuki F; Nagahashi T; Sawamura Y; Fukuda S
Nihon Jibiinkoka Gakkai Kaiho; 2006 May; 109(5):433-9. PubMed ID: 16768158
[TBL] [Abstract][Full Text] [Related]
11. Treatment modalities and outcomes of olfactory neuroblastoma.
Song CM; Won TB; Lee CH; Kim DY; Rhee CS
Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
[TBL] [Abstract][Full Text] [Related]
12. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
[TBL] [Abstract][Full Text] [Related]
14. Long-term analysis of multimodality treatment outcomes and prognosis of esthesioneuroblastomas: a single center results of 138 patients.
Sun M; Wang K; Qu Y; Zhang J; Zhang S; Chen X; Wang J; Wu R; Zhang Y; Yi J; Xiao J; Xu G; Huang X; Luo J
Radiat Oncol; 2020 Sep; 15(1):219. PubMed ID: 32948223
[TBL] [Abstract][Full Text] [Related]
15. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
16. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: the Northwestern University experience.
Argiris A; Dutra J; Tseke P; Haines K
Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of 34 cases of esthesioneuroblastoma].
Liu WS; Tang PZ; Xu GZ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
[TBL] [Abstract][Full Text] [Related]
20. Nasal and paranasal esthesioneuroblastomas: clinical outcomes.
Michel J; Fakhry N; Santini L; Mancini J; Giovanni A; Dessi P
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Oct; 129(5):238-43. PubMed ID: 22341153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
